» Authors » A F List

A F List

Explore the profile of A F List including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 96
Citations 1264
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
OSullivan J, Taylor J, Gerds A, Buckley S, Harrison C, Oh S, et al.
Leukemia . 2023 Oct; 37(12):2497-2501. PMID: 37864122
No abstract available.
2.
Zhang Q, Ball M, Zhao Y, Balasis M, Letson C, Vedder A, et al.
Leukemia . 2017 Jul; 32(2):532-538. PMID: 28694526
The interplay between tumor heterogeneity and microenvironmental factors is a critical mechanism for clonal selection in leukemia. Evidence of unique clonal capacities to engraft within patient-derived xenograft (PDX) models suggests...
3.
Negoro E, Radivoyevitch T, Polprasert C, Adema V, Hosono N, Makishima H, et al.
Leukemia . 2016 Aug; 30(12):2405-2409. PMID: 27560106
No abstract available.
4.
List A, Bennett J, Sekeres M, Skikne B, Fu T, Shammo J, et al.
Leukemia . 2015 Dec; 29(12):2452. PMID: 26648407
No abstract available.
5.
Komrokji R, List A
Ann Oncol . 2015 Oct; 27(1):62-8. PMID: 26504152
The treatment of patients with myelodysplastic syndromes (MDS) begins with assessment of karyotype and risk. Lenalidomide is approved for the treatment of patients who have transfusion-dependent anemia due to lower-risk...
6.
Padron E, Garcia-Manero G, Patnaik M, Itzykson R, Lasho T, Nazha A, et al.
Blood Cancer J . 2015 Aug; 5:e333. PMID: 26230957
Since its reclassification as a distinct disease entity, clinical research efforts have attempted to establish baseline characteristics and prognostic scoring systems for chronic myelomonocytic leukemia (CMML). Although existing data for...
7.
McGraw K, Zhang L, Rollison D, Basiorka A, Fulp W, Rawal B, et al.
Blood Cancer J . 2015 Mar; 5:e291. PMID: 25768405
Nonsynonymous TP53 exon 4 single-nucleotide polymorphism (SNP), R72P, is linked to cancer and mutagen susceptibility. R72P associations with specific cancer risk, particularly hematological malignancies, have been conflicting. Myelodysplastic syndrome (MDS)...
8.
Sekeres M, Swern A, Fenaux P, Greenberg P, Sanz G, Bennett J, et al.
Blood Cancer J . 2014 Aug; 4:e242. PMID: 25171203
No abstract available.
9.
List A, Bennett J, Sekeres M, Skikne B, Fu T, Shammo J, et al.
Leukemia . 2013 Oct; 28(5):1033-40. PMID: 24150217
Lenalidomide is the approved treatment for patients with red blood cell (RBC) transfusion-dependent lower-risk myelodysplastic syndromes (MDS) and chromosome 5q deletion (del(5q)). We report the long-term outcomes (median follow-up 3.2...
10.
Khan S, Jankowska A, Mahfouz R, Dunbar A, Sugimoto Y, Hosono N, et al.
Leukemia . 2013 Mar; 27(6):1301-9. PMID: 23486531
Polycomb repressive complex 2 (PRC2) is involved in trimethylation of histone H3 lysine 27 (H3K27), chromatin condensation and transcriptional repression. The silencing function of PRC2 complex is mostly attributed to...